SARS-CoV-2 vaccine
The accelerated response to Covid-19 includes investments in preclinical and clinical testing and manufacture of multiple vaccine candidates.
There is a large global effort to develop vaccines for protection against COVID-19 and at least 19 vaccine candidates.
A COVID‑19 vaccine is a biotechnology product intended to provide acquired immunity against coronavirus disease 2019 (COVID-19)
Interesado en saber si los programas clínicos actuales, desarrollos de investigacion, o enfoques terapéuticos emergentes pueden ser relevantes para su situación?
Información educativa y de investigación únicamente.. Las decisiones médicas individuales deben tomarse en consulta con profesionales sanitarios cualificados..
